Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents (Q34002682)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents |
scientific article |
Statements
1 reference
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents (English)
1 reference
D Euan MacIntyre
1 reference
Alison M Strack
1 reference
Tung M Fong
1 reference
Lauren P Shearman
1 reference
Xiao-Ming Guan
1 reference
Donald J Marsh
1 reference
Chun-Pyn Shen
1 reference
D Sloan Stribling
1 reference
Kim M Rosko
1 reference
Julie Lao
1 reference
Hong Yu
1 reference
Yue Feng
1 reference
Jing C Xiao
1 reference
Lex H T Van der Ploeg
1 reference
Mark T Goulet
1 reference
Williams K Hagmann
1 reference
Linus S Lin
1 reference
Thomas J Lanza
1 reference
James P Jewell
1 reference
Ping Liu
1 reference
Shrenik K Shah
1 reference
Hongbo Qi
1 reference
Xinchun Tong
1 reference
Junying Wang
1 reference
Suoyu S Xu
1 reference
Barbara Francis
1 reference
27 February 2007
1 reference
1 reference
Identifiers
1 reference